BEIJING, June 16th: The Chinese company Synovik Biotech Limited says its coronavirus vaccine has the potential to stimulate a patient’s health and immune system during human trials.
Experts have hinted that the vaccine could be a strong defense against the new virus, Covid-19. According to company data, the vaccine, does not have a negative effect on the patient during human trials. The people who tested it developed strong and effective immunity against Covid-19 two weeks later, including antibodies needed to neutralize the virus.
According to a statement issued by the Beijing-based company, the first and second stages of the vaccine in humans. Preliminary results were released, which included 743 healthy people between the ages of 18 and 59. The first phase involved 143 people, while the second phase involved 600 people.
The people who were vaccinated had more than 90% levels of antibodies to the virus after 14 days, but no serious side effects were seen.
According to a company spokesperson, the results of the vaccine on another group will be released soon. The trial period was 28 days and these results will be published in educational journals.
Stay tuned to Baaghi TV for latest news and updates !
